Literature DB >> 1717900

Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brain.

N Iwamoto1, P C Emson.   

Abstract

The pathological changes occurring in a population of parvalbumin-like immunoreactive cerebral cortical interneurones in postmortem Alzheimer-type dementia brain tissue were determined by double staining cerebral cortical sections for parvalbumin, tau and/or calpain-like immunoreactivities. By counting the number of double immunostained cells it was determined that 4% parvalbumin and 25% of calpain-like immunoreactive cells showed evidence of tau-like immunoreactivity, indicative of neurofibrillary tangles. These results suggest that cerebral cortical parvalbumin-like immunoreactive neurones are relatively resistant to the pathological changes underlying the formation of neurofibrillary tangles associated with Alzheimer-type dementia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717900     DOI: 10.1016/0304-3940(91)90764-k

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 2.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

Review 3.  Selective vulnerability in neurodegenerative diseases.

Authors:  Hongjun Fu; John Hardy; Karen E Duff
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

4.  Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients.

Authors:  Lidia Blazquez-Llorca; Virginia Garcia-Marin; Javier Defelipe
Journal:  Front Neuroanat       Date:  2010-06-24       Impact factor: 3.856

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.